KLK3 and prostate carcinoma: Though patients with clinical evidence suggestive of high-risk prostate cancer (either an extracapsular extension or prostate-specific antigen [PSA] level > 20 ng/ml) have csPCa regardless of the Gleason score (GS) if diagnosed with prostate cancer, a systematic biopsy cannot be performed according to current guidelines.